Is Amazon planning to disrupt the $560B prescription drug market?
All the buzz out of Amazon these days indicates that the online juggernaut is looking to disrupt the giant US healthcare market. And now the rumblings point to a potential Amazon earthquake in the $560 billion prescription pharmaceuticals market.
Goldman Sachs assembled a 30-page report that essentially outlined how Amazon could revamp an industry noted for its puzzling pricing models, with potential for revolutionizing the way Americans order and get their drugs on a mass scale. Pharmacies would be unlikely to celebrate any of this, but the analysts see Amazon’s entry as one way to solve the puzzle on pricing transparency, while opening up broad access to a huge market with lots of cross-selling potential.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.